TRAVOGEN

This brand name is authorized in Austria, Cyprus, Estonia, Hong Kong SAR China, Lithuania, Malta, Poland, Romania, Singapore, Turkey.

Active ingredients

The drug TRAVOGEN contains one active pharmaceutical ingredient (API):

1	Isoconazole UNII 5AS8P3N30X - ISOCONAZOLE NITRATE
	Isoconazole is for use in the treatment of superficial fungal diseases of the skin. It displays a very broad spectrum of antimicrobial action. It is effective against dermatophytes and yeasts, yeast-like fungi (including the causative organism of pityriasis versicolor) and molds, as well against gram-positive bacteria in-vitro and against the causative organism of erythrasma.
	Read more about Isoconazole

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D01AC05	Isoconazole	D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AC Imidazole and triazole derivatives
Discover more medicines within D01AC05
G01AF07	Isoconazole	G Genito urinary system and sex hormones → G01 Gynecological antiinfectives and antiseptics → G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS → G01AF Imidazole derivatives
Discover more medicines within G01AF07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1000348, 1060928, 1820191, 1820203, 1865156, 1865167
HK	Department of Health Drug Office	43660
LT	Valstybinė vaistų kontrolės tarnyba	1007949, 1075082, 1079564, 1080814, 1081506
MT	Medicines Authority	PI908/03801A
PL	Rejestru Produktów Leczniczych	100025557, 100067656, 100257434, 100258379, 100259692, 100385161, 100391635, 100392557, 100393002, 100398459, 100423810
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W66598001, W66598002
SG	Health Sciences Authority	05333P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699514350200, 8699514350279